Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.
Neurochem Int. 2021 Jan;142:104919. doi: 10.1016/j.neuint.2020.104919. Epub 2020 Nov 23.
Alzheimer's disease (AD) is a progressive neurodegenerative disease which causes a non-reversible cognitive impairment and dementia. The primary cause of late-onset AD remains unknown although its pathology was discovered over a century ago. Recently, the vascular hypothesis of AD has received backing from evidence emerging from neuroimaging studies which have revealed the presence of a significant hypoperfusion in the brain regions vulnerable to AD pathology. In fact, hypoxia can explain many of the pathological changes evident in AD pathology, e.g. the deposition of β-amyloid plaques and chronic low-grade inflammation. Hypoxia-inducible factor-1α (HIF-1α) stimulates inflammatory responses and modulates both innate and adaptive immunity. It is known that hypoxia-induced inflammation evokes compensatory anti-inflammatory response involving tissue-resident microglia/macrophages and infiltrated immune cells. Hypoxia/HIF-1α induce immunosuppression by (i) increasing the expression of immunosuppressive genes, (ii) stimulating adenosinergic signaling, (iii) enhancing aerobic glycolysis, i.e. lactate production, and (iv) augmenting the secretion of immunosuppressive exosomes. Interestingly, it seems that these common mechanisms are also involved in the pathogenesis of AD. In AD pathology, an enhanced immunosuppression appears, e.g. as a shift in microglia/macrophage phenotypes towards the anti-inflammatory M2 phenotype and an increase in the numbers of regulatory T cells (Treg). The augmented anti-inflammatory capacity promotes the resolution of acute inflammation but persistent inflammation has crucial effects not only on immune cells but also harmful responses to the homeostasis of AD brain. I will examine in detail the mechanisms of the hypoperfusion/hypoxia-induced immunosuppressive state in general and especially, in its association with AD pathogenesis. These immunological observations support the vascular hypothesis of AD pathology.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,可导致不可逆转的认知障碍和痴呆。尽管该病的病理学在一个多世纪前就已被发现,但晚发性 AD 的主要病因仍不清楚。最近,AD 的血管假说得到了神经影像学研究证据的支持,这些研究揭示了 AD 病理学易损脑区存在显著的灌注不足。事实上,缺氧可以解释 AD 病理学中许多明显的病理变化,例如β-淀粉样斑块的沉积和慢性低度炎症。缺氧诱导因子-1α(HIF-1α)可刺激炎症反应,并调节固有和适应性免疫。已知缺氧诱导的炎症会引发涉及组织驻留的小胶质细胞/巨噬细胞和浸润免疫细胞的代偿性抗炎反应。缺氧/HIF-1α 通过以下方式诱导免疫抑制:(i)增加免疫抑制基因的表达,(ii)刺激腺苷能信号,(iii)增强有氧糖酵解,即乳酸产生,以及(iv)增加免疫抑制外泌体的分泌。有趣的是,这些共同的机制似乎也参与了 AD 的发病机制。在 AD 病理学中,增强的免疫抑制作用似乎出现,例如小胶质细胞/巨噬细胞表型向抗炎 M2 表型的转变以及调节性 T 细胞(Treg)数量的增加。增强的抗炎能力促进了急性炎症的消退,但持续性炎症不仅对免疫细胞,而且对 AD 大脑的内稳态的有害反应都有至关重要的影响。我将详细研究灌注不足/缺氧诱导的免疫抑制状态的机制,特别是其与 AD 发病机制的关系。这些免疫学观察结果支持 AD 病理学的血管假说。